Not unlike Oxy186 [23], Oxy210 also displays anti-proliferative properties in NSCLC cells as a standalone agent, a likely consequence of Gli inhibition, rather than TGFβ inhibition (Figure 6a–c and Figure 7a,b). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.